Optimal Diagnostic and Therapeutic Strategies to Improve Patient Outcomes in Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) carries a high morbidity rate with patients often experiencing poor-quality of life due to significant impairments in their function in normal daily activities and independence. Given the devastating impact of IPF, there has been a great deal of research over the last decade.

An expert panel will discuss new and emerging clinical trial data, treatment guidelines, and strategies to improve overall quality of life. This CME activity will bring clinicians up-to-date on the management of patients with IPF for optimal outcomes.

Target Audience

Pulmonologists, respiratory specialists, internists, primary care physicians, nurse practitioners, physician assistants, and healthcare professionals responsible for the diagnosis, treatment, or management of patients with idiopathic pulmonary fibrosis.

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Discuss the ATS/ERS/JRS/ALAT treatment guidelines for patient screening and management.
  2. Analyze clinical trial data of emerging therapeutics for IPF, and evaluate the safety and efficacy profiles of mono- and combination-therapy regimens.
  3. Integrate disease monitoring tactics and appropriate therapy selection strategies into personalized treatment plans to improve outcomes and overall quality of life in patients with IPF.

Faculty

Gerard J. Criner, MD
Professor of Medicine
Director, Division of Pulmonary and Critical Care Medicine
Temple University School of Medicine
Philadelphia, PA

Namrata Patel, MD
Associate Professor of Medicine
Division of Pulmonary and Critical Care Medicine
Temple University School of Medicine
Philadelphia, PA

Francis Cordova, MD
Professor of Medicine
Medical Director, Lung Transplantation Program
Temple University School of Medicine
Philadelphia, PA

Michelle Vega-Olivo, CRNP
Pulmonary Nurse Practitioner
Temple Lung Center
Philadelphia, PA

Disclosure Statements

It is the policy of the Elsevier Office of Continuing Medical Education that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity. 

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Faculty                                  

Relationship Identified With:

Gerard J. Criner, MD

Nothing to disclose.

Francis Cordova, MD

Research Grant: Boehringer Ingelheim Pharmaceuticals, Inc.; InterMune

Namrata Patel, MD

Consultant/Advisor: InterMune

Michelle Vega-Olivo, CRNP

Nothing to disclose.

Planners, Managers, Reviewers: Sandy Breslow; Brynne Hunter; Jacquelyn Valerio; Timothy Hayes, MD, PhD; Kristen Scollon; Emma Gilmartin; Jaimie Kelly; and Bernard Abrams, MD  hereby state that they or their spouse/life partner do not have any financial relationships to products or devices with any commercials interest related to the content of this activity of any amount during the past 12 months. 

Financial Support

This activity has been supported by independent educational grants from InterMune and Genentech, Inc.

Provider Information 

Co-provided by The Elsevier Office of Continuing Medical Education and AcademicCME.



Course Open Date: May 14, 2015 | Course Expiration Date: May 13, 2016

CME Credit (Physicians)

The Elsevier Office of Continuing Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Elsevier Office of Continuing Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Inquiries/Special Needs

For all CME inquiries or special needs, please contact elsevierCME@elsevier.com.


Disclosure of Unlabeled Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Elsevier Office of Continuing Medical Education, AcademicCME, InterMune, and Genentech, Inc. do not recommend the use of any agent outside of the labeled indications.

Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Course summary
Course opens: 
05/14/2015
Course expires: 
05/13/2016
Rating: 
5

Available Credit

Accreditation Period

Course opens: 
05/14/2015
Course expires: 
05/13/2016
Please login or register to take this course.